Do NAD+ precursors improve exercise performance?
Weak EvidenceNO
Weak evidence for performance benefits. While NAD+ precursors (NR, NMN) successfully raise blood NAD+ levels, human trials have largely failed to demonstrate meaningful improvements in exercise performance, VO2max, or endurance in healthy adults.
The Verdict
Weak evidence for performance benefits. While NAD+ precursors (NR, NMN) successfully raise blood NAD+ levels, human trials have largely failed to demonstrate meaningful improvements in exercise performance, VO2max, or endurance in healthy adults.
What the Evidence Shows
Nicotinamide adenine dinucleotide (NAD+) is a critical coenzyme in mitochondrial energy production, and its levels decline with age. NAD+ precursors—nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN)—effectively raise circulating NAD+ levels by 40-90% in human studies. The theoretical rationale for performance enhancement is compelling: higher NAD+ should improve mitochondrial function, enhance fatty acid oxidation, and activate sirtuins (SIRT1/SIRT3) that regulate mitochondrial biogenesis. However, translating these biochemical changes into functional performance improvements has proven difficult. Multiple RCTs in healthy young and middle-aged adults have shown no significant improvements in VO2max, time-to-exhaustion, power output, or running economy with NR or NMN supplementation at typical doses (250-1000mg/day for 4-12 weeks). One exception is a small study by Liao et al. (2022) showing NMN improved ventilatory threshold in amateur runners, but this awaits replication. The disconnect between elevated NAD+ levels and performance may be because: (1) healthy exercising adults already have adequate mitochondrial NAD+ from training-induced biogenesis, (2) raising blood NAD+ does not proportionally increase intramuscular NAD+, or (3) the bottleneck for performance is not NAD+ availability. Older or sedentary populations with genuine NAD+ depletion may benefit more, but data remain preliminary.
Evidence Quality
0
Meta-Analyses
5
RCTs
2
Observational
Important Caveats
- ⚠️ Blood NAD+ increases do not necessarily reflect intramuscular NAD+ changes
- ⚠️ Healthy trained individuals may already have optimized mitochondrial NAD+
- ⚠️ Most trials are small (n<30) and short-term (4-12 weeks)
- ⚠️ Older or untrained populations might respond differently but data are limited
- ⚠️ Long-term safety at supplement doses (500-1000mg/day) is not fully established
Population Studied
Healthy adults (20-65); recreational and trained athletes; some studies in sedentary middle-aged adults; primarily male participants
Dosage
NR: 250-1000mg/day; NMN: 250-1200mg/day; typically taken orally in divided doses
Duration
Most RCTs span 4-12 weeks; some acute single-dose studies; no long-term (>6 month) performance data
Supporting Studies (2)
Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study
RCTLiao B, Zhao Y, Wang D, et al. · Journal of the International Society of Sports Nutrition (2022)
6 weeks of NMN (300, 600, or 1200mg/day) improved ventilatory threshold and time to exhaustion during incremental exercise in amateur runners (n=48), with dose-dependent effects at the 600 and 1200mg doses.
View paper (DOI) →Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults
RCTMartens CR, Denman BA, Mazzo MR, et al. · Nature Communications (2018)
6 weeks of NR (1000mg/day) raised NAD+ metabolites by 60% and showed trends toward reduced blood pressure and arterial stiffness in healthy middle-aged adults, suggesting cardiovascular benefits that could indirectly support exercise capacity.
View paper (DOI) →Contradicting Studies (1)
Nicotinamide riboside supplementation does not alter whole-body or skeletal muscle metabolic profiles in healthy adults
RCTRemie CME, Roumans KHM, Moonen MPB, et al. · American Journal of Clinical Nutrition (2020)
6 weeks of NR (1000mg/day) in healthy overweight adults increased circulating NAD+ metabolites but did not improve mitochondrial function, skeletal muscle acetylcarnitine content, exercise efficiency, or any performance measure compared to placebo.
Why this disagrees:
Despite successfully elevating blood NAD+, the supplement failed to translate into any measurable metabolic or performance improvement in muscle tissue, suggesting a disconnect between systemic NAD+ levels and functional mitochondrial benefit in healthy humans.
Related Claims
Does CoQ10 improve heart health?
Moderate EvidenceModerate evidence supports CoQ10 supplementation for heart failure patients, with the Q-SYMBIO trial showing reduced cardiovascular mortality. Evidence for prevention in healthy individuals is weaker, and benefits for statin-related muscle pain are inconsistent.
Does NAD+ supplementation reverse aging?
Weak EvidenceWeak evidence for anti-aging effects in humans. NAD+ precursors (NMN, NR) reliably increase blood NAD+ levels, but no human trials have demonstrated reversal of aging biomarkers, functional improvements, or lifespan extension. Animal data is promising but translation remains unproven.
Does nicotinamide riboside reverse aging?
Weak EvidenceWeak evidence supports nicotinamide riboside (NR) for anti-aging in humans. While NR reliably boosts NAD+ levels in blood, human trials have not demonstrated meaningful improvements in aging biomarkers, physical function, or healthspan outcomes despite strong preclinical data.